Anavex Life Sciences Corp (AVXL)

[Lima4918]

Coiled spring.

You should cover.

S&P price target $17.25
Janney price target $10

Did you hear former FDA commissioner yesterday say that the next best thing is "neurodegenration" targets, and that this presents the "biggest opportunity?"

Did you read Investors Business Daily this weekend? It explicitly covered The Approach Anavex is taking to treat Alzheimer's.

It's Anavex's time. Why? Because Anavex is now at the intersection of Mainstreet and WallStreet.

I think Janney is covering Anavex because Anavex is at the M&A table!!!!